FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967678736> ?p ?o ?g. }

• W1967678736 endingPage "899" @default.
• W1967678736 startingPage "890" @default.
• W1967678736 abstract "Less frequent bisphosphonate dosing in women with postmenopausal osteoporosis has the potential to promote therapy adherence through improved convenience. Ibandronate is a highly potent nitrogen-containing bisphosphonate, proven to significantly increase vertebral and nonvertebral bone mineral density (BMD) when administered as a convenient intravenous injection. A recent double-blind, placebo-controlled, randomized phase III study explored the antifracture efficacy and safety of 1 and 0.5 mg iv ibandronate injections, given once every 3 months, in 2862 women (55-76 years) with postmenopausal osteoporosis [one to four prevalent vertebral fractures and lumbar spine (L1-L4) BMD T score of less than -2.0 and greater than -5.0 in >or=1 vertebra]. All participants received daily vitamin D (400 IU) and calcium (500 mg) supplementation. The primary endpoint was the incidence of new morphometric vertebral fractures after 3 years. However, although a consistent trend toward a reduction in the incidence of new morphometric vertebral fracture was observed in the active treatment arms compared with placebo (9.2% vs. 8.7% vs. 10.7% in the 1 mg, 0.5 mg and placebo groups, respectively), as well as in the incidence of nonvertebral and hip fractures, the magnitude of fracture reduction was suboptimal and was insufficient to achieve statistical significance. At the studied doses, intravenous ibandronate injections also produced dose-dependent, but comparatively small, increases in lumbar spine BMD (4.0% and 2.9%, respectively) and decreases in biochemical markers of bone resorption and formation, relative to placebo. Optimal fracture efficacy likely requires more substantial increases in BMD and more pronounced suppression of bone turnover. In light of the clear dose-response relationship observed in this and other studies, this is likely to be achieved with higher intravenous doses of ibandronate. The results of a recent phase II/III study (Intermittent Regimen Intravenous Ibandronate Study: the IRIS study) provide support for this hypothesis." @default.
• W1967678736 created "2016-06-24" @default.
• W1967678736 creator A5005612011 @default.
• W1967678736 creator A5007262708 @default.
• W1967678736 creator A5012062684 @default.
• W1967678736 creator A5013115644 @default.
• W1967678736 creator A5017610569 @default.
• W1967678736 creator A5021172865 @default.
• W1967678736 creator A5027234402 @default.
• W1967678736 creator A5052478195 @default.
• W1967678736 creator A5077884182 @default.
• W1967678736 creator A5079874524 @default.
• W1967678736 date "2004-05-01" @default.
• W1967678736 modified "2023-10-16" @default.
• W1967678736 title "Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis" @default.
• W1967678736 cites W1883130365 @default.
• W1967678736 cites W1984207232 @default.
• W1967678736 cites W1995580211 @default.
• W1967678736 cites W1997629391 @default.
• W1967678736 cites W1999949526 @default.
• W1967678736 cites W2012291531 @default.
• W1967678736 cites W2036222335 @default.
• W1967678736 cites W2042004810 @default.
• W1967678736 cites W2062575592 @default.
• W1967678736 cites W2070815981 @default.
• W1967678736 cites W2072797307 @default.
• W1967678736 cites W2073141330 @default.
• W1967678736 cites W2087929119 @default.
• W1967678736 cites W2089272876 @default.
• W1967678736 cites W2104515255 @default.
• W1967678736 cites W2110828193 @default.
• W1967678736 cites W2112629831 @default.
• W1967678736 cites W2113156567 @default.
• W1967678736 cites W2134664830 @default.
• W1967678736 cites W2145594868 @default.
• W1967678736 cites W4236210233 @default.
• W1967678736 doi "https://doi.org/10.1016/j.bone.2004.01.008" @default.
• W1967678736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15121021" @default.
• W1967678736 hasPublicationYear "2004" @default.
• W1967678736 type Work @default.
• W1967678736 sameAs 1967678736 @default.
• W1967678736 citedByCount "155" @default.
• W1967678736 countsByYear W19676787362012 @default.
• W1967678736 countsByYear W19676787362013 @default.
• W1967678736 countsByYear W19676787362014 @default.
• W1967678736 countsByYear W19676787362015 @default.
• W1967678736 countsByYear W19676787362016 @default.
• W1967678736 countsByYear W19676787362017 @default.
• W1967678736 countsByYear W19676787362018 @default.
• W1967678736 countsByYear W19676787362019 @default.
• W1967678736 countsByYear W19676787362020 @default.
• W1967678736 countsByYear W19676787362021 @default.
• W1967678736 countsByYear W19676787362022 @default.
• W1967678736 countsByYear W19676787362023 @default.
• W1967678736 crossrefType "journal-article" @default.
• W1967678736 hasAuthorship W1967678736A5005612011 @default.
• W1967678736 hasAuthorship W1967678736A5007262708 @default.
• W1967678736 hasAuthorship W1967678736A5012062684 @default.
• W1967678736 hasAuthorship W1967678736A5013115644 @default.
• W1967678736 hasAuthorship W1967678736A5017610569 @default.
• W1967678736 hasAuthorship W1967678736A5021172865 @default.
• W1967678736 hasAuthorship W1967678736A5027234402 @default.
• W1967678736 hasAuthorship W1967678736A5052478195 @default.
• W1967678736 hasAuthorship W1967678736A5077884182 @default.
• W1967678736 hasAuthorship W1967678736A5079874524 @default.
• W1967678736 hasConcept C120665830 @default.
• W1967678736 hasConcept C121332964 @default.
• W1967678736 hasConcept C126322002 @default.
• W1967678736 hasConcept C126894567 @default.
• W1967678736 hasConcept C141071460 @default.
• W1967678736 hasConcept C142724271 @default.
• W1967678736 hasConcept C168563851 @default.
• W1967678736 hasConcept C170033053 @default.
• W1967678736 hasConcept C203092338 @default.
• W1967678736 hasConcept C204787440 @default.
• W1967678736 hasConcept C27081682 @default.
• W1967678736 hasConcept C2776541429 @default.
• W1967678736 hasConcept C2776886416 @default.
• W1967678736 hasConcept C2777251235 @default.
• W1967678736 hasConcept C61511704 @default.
• W1967678736 hasConcept C673006 @default.
• W1967678736 hasConcept C71924100 @default.
• W1967678736 hasConceptScore W1967678736C120665830 @default.
• W1967678736 hasConceptScore W1967678736C121332964 @default.
• W1967678736 hasConceptScore W1967678736C126322002 @default.
• W1967678736 hasConceptScore W1967678736C126894567 @default.
• W1967678736 hasConceptScore W1967678736C141071460 @default.
• W1967678736 hasConceptScore W1967678736C142724271 @default.
• W1967678736 hasConceptScore W1967678736C168563851 @default.
• W1967678736 hasConceptScore W1967678736C170033053 @default.
• W1967678736 hasConceptScore W1967678736C203092338 @default.
• W1967678736 hasConceptScore W1967678736C204787440 @default.
• W1967678736 hasConceptScore W1967678736C27081682 @default.
• W1967678736 hasConceptScore W1967678736C2776541429 @default.
• W1967678736 hasConceptScore W1967678736C2776886416 @default.
• W1967678736 hasConceptScore W1967678736C2777251235 @default.
• W1967678736 hasConceptScore W1967678736C61511704 @default.
• W1967678736 hasConceptScore W1967678736C673006 @default.

• next